General MedicationsINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSStandard
EPINEPHRINE
EPINEPHRINE
Standard Dose
10MG/10ML (1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 219239 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML) Sponsor GLAND Submission history Latest submission status date: 2025-02-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 219239 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML) Sponsor GLAND Submission history Latest submission status date: 2025-02-06 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.